News & Events

As a reflection of its mission statement to providing smart solutions and innovative products to the GCC market, Zahrawi Group teams showed a strong presence alongside our partners during the Arab Health 2022, the MENA region’s leading exhibition for the healthcare industry that took place on 24-27 January at the Dubai World Trade Centre. The […]

Read more

We are pleased to announce that our Molecular, Immunology and Microbiology team in UAE has received the “Growth Champion Genomics 2021” award handed by Agilent during the CY 2021 Result & Awards Celebration on the 17th January 2022. United Arab Emirates is a high potential market where Zahrawi Group have excelled and registered the highest […]

Read more

We are proud to announce that our Structural Heart & Neuromodulation unit in KSA has successfully implanted a Watchman FLX device from our partner Boston Scientific at National Guard Health Affairs Jeddah (King Faisal Cardiac Center), where Dr. Abdullah Alsaeidi, Dr. Wail Alkashkari, Dr. Fahad Almehmadi and the Cath lab team operated on a 60-years+ […]

Read more

We are pleased to announce that our Histopathology & Cytology team in UAE has achieved a major accomplishment. Indeed, Zahrawi Group has received the “EMEAI Best Regional Performer Pathology 2021” award handed by Agilent during the CY 2021 Result & Awards Celebration on the 17th January 2022. United Arab Emirates is a mature market where […]

Read more

We are proud to announce that our Structural Heart & Neuromodulation unit in KSA has successfully implanted a Watchman FLX device from our partner Boston Scientific at King Fahad University Hospital in Khobar, where Dr. Mansouri and his team operated a 61-year-old patient with repeated TIAs and who was suffering from Atrial Fibrillation. The new […]

Read more